Image results are for simulation only and may not reflect actual outcomes.
Actual Natrelle® patient.
Individual results may vary.
3D Breast Visualizer
with the Natrelle® 3D Breast Visualizer powered by Crisalix
Redefine the modern patient journey with Crisalix* cutting-edge 3D Breast Visualizer technology.
Request a demo*Crisalix services are offered on a paid subscription basis directly through Crisalix. AbbVie Inc. does not own, control, set, or guarantee Crisalix services, features, availability, or pricing. Pricing and subscription terms are determined by Crisalix. AbbVie makes no warranties, express or implied, regarding Crisalix services.
Actual Natrelle® patient.
Individual results may vary.
3D Breast Visualizer
The enhanced partnership* between Natrelle® and Crisalix keeps patients informed and connected to your practice by streamlining the journey from in-home exploration to in-office consultation.
*Crisalix services are offered on a paid subscription basis directly through Crisalix. AbbVie Inc. does not own, control, set, or guarantee Crisalix services, features, availability, or pricing. Pricing and subscription terms are determined by Crisalix. AbbVie makes no warranties, express or implied, regarding Crisalix services.
Request a demoStart their augmentation journey from home with a custom provider link.
Patients access the Natrelle® 3D Breast Visualizer powered by Crisalix through a Natrelle® banner on your website, which contains your new custom provider link to prompt practice-specific bookings.
Within the Natrelle® 3D Breast Visualizer In-Home App, patients will be led through three simple steps where they can visualize potential outcomes from the comfort of their own home, exploring different profile options. Transform curiosity into consultation when they use the new integrated consultation request feature to book an appointment directly with your office, all made possible through your paid subscription.*
Natrelle® New Custom Provider Link
Create a profile
Upload 3 Selfies
Visualize THEIR look with integrated Implant data
Book directly with your practice
Image results are for simulation only and may not reflect actual outcomes.
95%
of patients reported improved understanding, motivation, and consideration after using the 3D Breast Visualizer1.
Natrelle® 3D Breast Visualizer Survey Analysis conducted by Crisalix from January 2021 – December 2025. Responses collected from 550+ users of the Natrelle 3D Breast Visualizer app.
*Crisalix services are offered on a paid subscription basis directly through Crisalix. AbbVie Inc. does not own, control, set, or guarantee Crisalix services, features, availability, or pricing. Pricing and subscription terms are determined by Crisalix. AbbVie makes no warranties, express or implied, regarding Crisalix services.
Align with your patients at every step of their journey.
The Natrelle® 3D Breast Visualizer End-to-End Professional Solution elevates the patient experience from the very first interaction through post-consultation follow-up.
Patients begin their journey at home, using your practice’s custom provider link to explore possibilities and book a consultation. Once in-office, the Crisalix* exclusive 3D consultation platform, integrated with the entire Natrelle® implant catalog, empowers patients to visualize augmentation outcomes and consider a wider range of aesthetic options in detail.
This advanced, in-office technology supports smarter, collaborative conversations, helping physicians and patients align on expectations and make well-informed decisions. With seamless digital tools for capturing, simulating, planning and following up—all online and without the need for extra hardware—this comprehensive platform provides true visualization and conversion opportunities at every stage of the patient journey. Stay connected with patients before, during, and after consultation to help ensure continual engagement and satisfaction.
Integrated Natrelle® implant data enables high-quality visualization with more personalization options at the consultation stage.
In-office technology offers aesthetic variations beyond profile options.
Not an actual Natrelle® patient.
Image results are for simulation only and may not reflect actual outcomes.
*Crisalix services are offered on a paid subscription basis directly through Crisalix. AbbVie Inc. does not own, control, set, or guarantee Crisalix services, features, availability, or pricing. Pricing and subscription terms are determined by Crisalix. AbbVie makes no warranties, express or implied, regarding Crisalix services.
86%
of consultations convert into treatment when providers use the Crisalix solution in consultations2.
Physician user data conducted from January 2023-December 2025. Responses were collected from 572 Crisalix users.2.
94.8%
of patients reported that the solution improved the efficiency of clinical decision-making3.
Based on an online survey post-consultation conducted by Crisalix from January 2023 – December 2025. Responses were collected from 29,636 patients.
96.1%
of patients reported that the solution helped confirm their expectations and aesthetic preferences3.
Based on an online survey post-consultation conducted by Crisalix from January 2023 – December 2025. Responses were collected from 29,636 patients.
Beyond access to Natrelle® marketing assets provided by Allergan Aesthetics via BrandBox, the Crisalix paid subscription* offers more resources to elevate your connection and communication with patients.
Level up your practice’s marketing with customizable Crisalix promotional materials, marketing guidance, and ongoing support by Crisalix.
Natrelle® Marketing Materials Provided by Allergan Aesthetics via BrandBox.
Promote your practice and Natrelle® offerings today with BrandBox assets available to any practice offering Natrelle® implants.
Social post
Actual Natrelle® patient.
Individual results may vary.
Social post
Not an actual Natrelle® patient.
Social post
Social post
Actual Natrelle® patient.
Individual results may vary.
Crisalix Customized Marketing Materials via Paid Subscription*
Gain exclusive access to marketing materials customizable to your practice in addition to general Natrelle® promotional materials.
Website Image & Banner
Not an actual Natrelle® patient.
Blog image
Not an actual Natrelle® patient.
Social story
Image results are for simulation only and may not reflect actual outcomes.
Social post
Not an actual Natrelle® patient.
Social post
Not an actual Natrelle® patient.
*Crisalix services are offered on a paid subscription basis directly through Crisalix. AbbVie Inc. does not own, control, set, or guarantee Crisalix services, features, availability, or pricing. Pricing and subscription terms are determined by Crisalix. AbbVie makes no warranties, express or implied, regarding Crisalix services.
3D Breast Visualizer
What is the Natrelle® In-Home App Solution powered by Crisalix?
The Natrelle® In-Home App Solution is a digital platform that allows patients to begin their breast augmentation journey from home. Using a custom provider link, patients can visualize potential outcomes, explore options, and book consultations easily.
How does the Natrelle® 3D Breast Visualizer support patient engagement?
The Natrelle® 3D Breast Visualizer enables patients to see potential breast augmentation outcomes in 3D, helping them make informed decisions before their office visit, and facilitating more productive discussions with providers.
Do patients need to download an app to use the visualizer?
No, the 3D Breast Visualizer is accessible online via a custom link and does not require downloads or special hardware. For those who prefer it, an optional app is available after sign-up.
What benefits does the Natrelle® 3D Breast Visualizer End-to-End Professional Solution offer practices?
Practices gain seamless tools for patient engagement, digital simulation, planning, and follow-up, all integrated with Natrelle® implants. This supports improved patient experience, expectation alignment, and ongoing connection throughout the patient journey.
How accurate are the simulations in the Natrelle® 3D Breast Visualizer End-to-End Professional Solution?
Crisalix simulations are AI-driven and anatomically based visualizations intended for educational purposes. They are not intended to predict or guarantee surgical outcomes, but to support communication and expectation alignment between providers and patients. Image results are for simulation only and may not reflect actual outcomes.
What support and resources are available for practices?
Practices receive implementation assistance, training, workflow alignment, and ongoing support from Crisalix, including access to resources, live chat, a Customer Success Manager, and regular platform updates.
How can providers learn more or request a demo?
Providers can request additional information or schedule a complimentary product demonstration by contacting natrelleus@crisalix.com or filling out the form above.
Natrelle® Breast Implants IMPORTANT SAFETY INFORMATION
Natrelle® Breast Implants are indicated for women for the following:
Breast implant surgery should not be performed in:
Safety and effectiveness have not been established in patients with the following:
Possible adverse events with breast implant surgery include implant rupture with silicone implants, implant deflation with saline-filled implants, capsular contracture, reoperation, implant removal, pain, changes in nipple and breast sensation, infection, scarring, asymmetry, wrinkling, implant displacement/migration, implant palpability/visibility, breastfeeding complications, hematoma/seroma, implant extrusion, necrosis, delayed wound healing, infection, breast tissue atrophy/chest wall deformity, calcium deposits, and lymphadenopathy. Other systemic conditions have been reported with breast implants.
For more information, please see the full Directions for Use at https//www.rxabbvie.com.
To report a problem with Natrelle® Breast Implants, please call Allergan® at 1-800-624-4261.
The sale and distribution of this device is restricted to users and/or user facilities that provide information to patients about the risks and benefits of this device in the form and manner specified in the approved labeling provided by Allergan®.
References:
1. Data on file, Allergan Aesthetics, March 2026; 3D Visualizer Consumer Survey Analysis 2025.
2. Data on file, Allergan Aesthetics, March 2026; US Conversion Rate Data for Crisalix 2025.
3. Data on file, Allergan Aesthetics, March 2026; US Post Consultation Survey Data.